comparemela.com

Latest Breaking News On - Atricure inc - Page 4 : comparemela.com

AtriCure (NASDAQ:ATRC) Issues Earnings Results

AtriCure (NASDAQ:ATRC) Issues Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

AtriCure (NASDAQ:ATRC) Posts Earnings Results, Misses Estimates By $0 02 EPS

AtriCure (NASDAQ:ATRC – Get Free Report) released its earnings results on Wednesday. The medical device company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by ($0.02), Briefing.com reports. AtriCure had a negative net margin of 8.98% and a negative return on equity of 7.82%. The firm had revenue […]

AtriCure, Inc (NASDAQ:ATRC) Insider Sells $36,135 00 in Stock

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) insider Justin J. Noznesky sold 1,500 shares of the firm’s stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $24.09, for a total value of $36,135.00. Following the transaction, the insider now directly owns 71,284 shares of the company’s stock, […]

AtriCure, Inc (NASDAQ:ATRC) Insider Justin J Noznesky Sells 1,500 Shares

AtriCure, Inc (NASDAQ:ATRC) Insider Justin J Noznesky Sells 1,500 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

AtriCure (NASDAQ:ATRC) PT Lowered to $40 00 at Needham & Company LLC

AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective dropped by analysts at Needham & Company LLC from $46.00 to $40.00 in a report released on Thursday, Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. Needham & Company LLC’s price objective points to a potential upside of […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.